BENNETT, D. A., PHUN, L., POLK, J. F., et al (1998) Neuropharmacology of St John's Wort (Hypericum). Annals of Pharmacotherapy, 32, 1201–1208.
BESTIC, L. (1999) The suddenly fashionable wort. The Independent, p. 11, .
BOVE, G. M. (1998) Acute neuropathy after exposure to sun in a patient treated with St John's Wort. Lancet, 352, 1121–1122.
BROCKMOLLER, J., REUM, T., BAUER, S., et al (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry, 30 (suppl. 2), 94–101.
ERNST, E. (1999) Second thoughts about the safety of St John's Wort. Lancet, 354, 2014–2016.
GUY, W. (ed.)(1976) ECDEU Assessment Manual for Psychopharmacology.
, pp. 217–222. Rockville, MD: US Department of Health, Education and Welfare.
HAMILTON, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
HARRER, G., SCHMIDT, U., KUHN, U., et al (1999) Comparison of equivalence between the St John's Wort extract LoHyp–57 and fluoxetine. Arzneimittelforschung, 49, 289–296.
LANTZ, M. S., BUCHALTER, E. & GIAMBANCO, V. (1999) St John's Wort and antidepressant reactions in the elderly. Journal of Geriatric Psychiatry and Neurology, 12, 7–10.
LINDE, K., RAMIREZ, G., MULROW, C. D., et al (1996) St John's wort for depression – an overview and metaanalysis of randomised clinical trials. British Medical Journal, 313, 253–258.
MONTGOMERY, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
PEPPING, J. (1999) Alternative therapies – St John's Wort: Hypericum Perforatum. Amercian Journal of Health-System Pharmacy, 56, 329–330.
PHILIPP, M., KOHNEN, R. & HILLER, K.-O. (1999) Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multi-centre study of treatment for eight weeks. British Medical Journal, 319, 1534–1539.
VOLZ, H. P. (1997) Controlled clinical trials of hypericin extracts in depressed patients – an overview. Pharmacopsychiatry, 30 (suppl.), 72–76.
VORBACH, E. U., ARNOLDT, K. H. & HUBNER, W. D. (1997) Efficacy and tolerability of St John's Wort extract LI160 versus imipramine in patients with severe depressive episodes according to ICD–10. Pharmacopsychiatry, 30 (suppl.), 81–85.
WHEATLEY, D. (1997) LI160, an extract of St John's Wort, versus amitriptyline in mildly to moderately depressed outpatients – a controlled six-week clinical trial. Pharmacopsychiatry, 30 (suppl.), 77–80.
WHEATLEY, D. (1998) Hypericum extract potential in the treatment of depression. CNS Drugs, 9, 431–440.
WOELK, H., BURKARD, G. & GRUNWALD, J. (1994) Benefits and risks of the hypericum extract LI160: drug monitoring study with 3250 patients. Journal of Geriatric Psychiatry and Neurology, 7 (suppl. 1), S34–38.
WONG, A. H. C., SMITH, M. & BOON, H. S. (1998) Herbal remedies in psychiatric practice. Archives of General Psychiatry, 55, 1033–1044.
WORLD HEALTH ORGANIZATION (1992) The Tenth Revision of the International Classification of Mental and Behavioural Disorders
. Geneva: WHO.
ZERSSEN, D., VON STRIAN, F. & SCHWARZ, D. (1974) Evaluation of depressive states, especially in longitudinal studies. In Psychological Measurements in Psychopharmacology (eds PICHOT, P. & OLIVIER-MARTIN, R.), pp.189–203. Basel: Karger.